UBS lowered the firm’s price target on Oklo (OKLO) to $60 from $95 and keeps a Neutral rating on the shares. UBS remains cautiously optimistic on the outlook for U.S. nuclear development broadly with concerns over capital needs for project development and potential delays and cost overruns, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKLO:
- Altman Drops Helion Board Seat to Clear Path for OpenAI’s Biggest Power Deal Yet
- OKLO Stock Forecast Gets Slashed by Goldman Sachs and Citi Analysts as ‘Pre-Revenue’ Reality Sinks In
- Oklo Inc. Earnings Call Shows Bold Nuclear Push
- Oklo price target lowered to $92 from $129 at B. Riley
- Oklo price target lowered to $65 from $91 at Goldman Sachs